Multimodal Nanomedicine Strategies for Targeting Cancer Cells as well as Cancer Stem Cell Signalling Mechanisms

Author(s): Jagat R. Kanwar*, Rasika M. Samarasinghe, Sishir K. Kamalapuram, Rupinder K. Kanwar

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 17 , Issue 18 , 2017

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Increasing evidence suggests that stem cells, a small population of cells with unique selfrenewable and tumour regenerative capacity, are aiding tumour re-growth and multidrug resistance. Conventional therapies are highly ineffective at eliminating these cells leading to relapse of disease and formation of chemoresistance tumours. Cancer and stem cells targeted therapies that utilizes nanotherapeutics to delivery anti-cancer drugs to specific sites are continuously investigated. This review focuses on recent research using nanomedicine and targeting entities to eliminate cancer cells and cancer stem cells. Current nanotherapeutics in clinical trials along with more recent publications on targeted therapies are addressed.

Keywords: Aptamers, cancer, chemotherapeutics, stem cells, nanotherapeutics, nanomedicine.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Page: [1688 - 1695]
Pages: 8
DOI: 10.2174/1389557516666160219121634
Price: $65

Article Metrics

PDF: 194